The overall goal of the Moffitt Cancer Center (MCC) Health Outcomes and Behavior (HOB) Program is to contribute to the prevention, detection, and control of cancer through the study of health-related behaviors, health care practices, and health-related quality of life. Work toward this goal involves research across the disease spectrum ? from prevention and detection through to survivorship or advanced disease. To accomplish its goal, the Program's Specific Aims are: (1) Understand the determinants of behaviors that can lead to prevention and early detection of cancer and develop effective methods of promoting those behaviors; (2) Understand and improve the quality of life of patients and family members throughout the disease course; (3) Contribute to the evidence base, and synthesis of evidence, regarding delivery of cancer care and clinical outcomes; and (4) Understand and intervene upon the social, cultural, and behavioral determinants of cancer- related health disparities. The program comprises 27 members [20 MCC faculty; seven University of South Florida (USF) faculty] from 12 different academic departments (six MCC and six USF). During the reporting period, 547 cancer-related articles have been published, with 218 (40%) representing intra-programmatic collaborations and 135 (25%) representing inter-programmatic collaborations. Inter-institutional collaborations with other NCI-designated Cancer Centers represent 164 (30%) of the publications. Total grant funding for the program currently is $9.1 million in annual total costs, of which $7.5 million is peer-reviewed, including $3.0 million from NCI. Program members conduct hypothesis-driven observational and intervention research on the major cancers affecting the catchment area?lung, prostate, breast, colorectal, cervical?with respect to prevention, screening, quality of life, cancer care delivery, and outcomes. Additionally, toward the goal of reducing cancer- related health disparities, program members conduct community-based participatory research in concert with organizations embedded in the catchment area. In collaboration with colleagues from other programs and institutions, translational research by HOB members is driving public health policy and clinical practice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA076292-19
Application #
9209829
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
2017-02-01
Budget End
2018-01-31
Support Year
19
Fiscal Year
2017
Total Cost
$31,374
Indirect Cost
$13,133
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
Research Institutes
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
de Mingo Pulido, Álvaro; Gardner, Alycia; Hiebler, Shandi et al. (2018) TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer. Cancer Cell 33:60-74.e6
Divakaran, Anand; Talluri, Siva K; Ayoub, Alex M et al. (2018) Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor. J Med Chem 61:9316-9334
McIntyre, Jessica; Jiménez, Julio; Rivera, Yonaira M et al. (2018) Comparison of Health Communication Channels for Reaching Hispanics About Biobanking: a Pilot Trial. J Cancer Educ 33:833-841
Li, Gongbo; Boucher, Justin C; Kotani, Hiroshi et al. (2018) 4-1BB enhancement of CAR T function requires NF-?B and TRAFs. JCI Insight 3:
Rivera, Y M; Moreno, L; Briant, K J et al. (2018) Developing Sustainable Cancer Education Programs: Training Public Health Students to Deliver Cancer 101 in Puerto Rico. J Cancer Educ 33:128-133
Saltos, Andreas; Khalil, Farah; Smith, Michelle et al. (2018) Clinical associations of mucin 1 in human lung cancer and precancerous lesions. Oncotarget 9:35666-35675
Gjyshi, Anxhela; Dash, Sweta; Cen, Ling et al. (2018) Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine. Sci Rep 8:8291
Maharaj, Kamira; Powers, John J; Achille, Alex et al. (2018) Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia. Blood Adv 2:3012-3024
Schaal, Courtney M; Bora-Singhal, Namrata; Kumar, Durairaj Mohan et al. (2018) Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer. Mol Cancer 17:149
Zhu, Genyuan; Brayer, Jason; Padron, Eric et al. (2018) OMIP-049: Analysis of Human Myelopoiesis and Myeloid Neoplasms. Cytometry A 93:982-986

Showing the most recent 10 out of 1254 publications